Fig. 1From: Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patientsMutations in the 21-gene panel in tumor samples from patients who underwent anti-EGFR therapy. Black squares indicate the presence of a mutation. The overall frequencies of gene mutations, as well as the frequencies in the responder and non-responder groups, are shown at the bottom of the figureBack to article page